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Abstract Genome-wide association studies (GWAS) have
identified a region at chromosome 1p21.3, containing the
microRNA MIR137, to be among the most significant asso-
ciations for schizophrenia. However, the mechanism bywhich
genetic variation at this locus increases risk of schizophrenia is
unknown. Identifying key regulatory regions around MIR137
is crucial to understanding the potential role of this gene in the
aetiology of psychiatric disorders. Through alignment of ver-
tebrate genomes, we identified seven non-coding regions at
the MIR137 locus with conservation comparable to exons
(>70 %). Bioinformatic analysis using the Psychiatric
Genomics Consortium GWAS dataset for schizophrenia
showed five of the ECRs to have genome-wide significant
SNPs in or adjacent to their sequence. Analysis of available
datasets on chromatin marks and histone modification data
showed that three of the ECRs were predicted to be functional
in the human brain, and three in development. In vitro analysis
of ECR activity using reporter gene assays showed that all
seven of the selected ECRs displayed transcriptional regula-
tory activity in the SH-SY5Y neuroblastoma cell line. This
data suggests a regulatory role in the developing and adult
brain for these highly conserved regions at the MIR137
schizophrenia-associated locus and further that these domains
could act individually or synergistically to regulate levels of
MIR137 expression.
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Introduction
Meta-analyses of schizophrenia genome-wide association
studies (GWAS) data have identified a locus on chromosome
1p21.3 (chr1:98,298,371–98,581,337, GRCh37/hg19) to be
among the most significantly associated regions for schizo-
phrenia (Ripke et al. 2013; Schizophrenia Psychiatric
Genome-Wide Association Study 2011). The microRNA
MIR137 is present within this locus, and subsequent work
has revealed transcripts from other schizophrenia-associated
loci as targets ofMIR137 (Collins et al. 2014; Kim et al. 2012;
Kwon et al. 2013), thereby suggesting MIR137-mediated reg-
ulation of a larger network of genes and pathways relevant to
mental illness. MIR137 is highly expressed in the brain and is
known to function in neural development and adult
neurogenesis (Smrt et al. 2010; Szulwach et al. 2010), as well
as regulating synaptic plasticity (Siegert et al. 2015).
Sequencing of the MIR137 locus by Duan et al. revealed
133 new variants which are enriched in non-coding sequences,
and one of these, a rare enhancer SNP 1:g.98515539 A> T,
was associated with schizophrenia and reduced enhancer ac-
tivity of its flanking sequence, predicting lower expression of
MIR137 (Duan et al. 2014). The authors predicted the location
of these SNPs as potential transcriptional regulators from
ENCODE data, including the use of histone marks such as
H3K4me1. We have previously shown that comparative ge-
nomics overlaid on SNP association data can identify non-
coding DNA which may be involved mechanistically in con-
ditions such as depression, alcoholism and obesity (Davidson
et al. 2011; Davidson et al. 2015; Hing et al. 2012). Using a
similar strategy to better understand the genomic regulatory
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architecture around the MIR137 locus, we used the evolution-
ary conserved region (ECR) and UCSC Genome Browsers to
align and compare multiple vertebrate genomes to identify and
prioritise conserved domains of interest. These regions were
further analysed using publically available schizophrenia
GWAS and epigenetic data, from the Psychiatric Genomics
Consortium and the Roadmap Epigenomics Consortium, re-
spectively. We herein identify seven functional ECRs at the
schizophrenia-associated MIR137 locus and characterise their
activities in vivo through analysis of epigenetic data, and
in vitro by dual luciferase reporter assays.
Materials and Methods
Bioinformatic Analysis
Bioinformatic analysis was carried out using ECR Browser
(http://ecrbrowser.dcode.org) and UCSC Genome Browser
(http://genome.ucsc.edu) to identify ECRs of interest at the
MIR137 locus. UCSC genome browser was also used to
overlay Psychiatric Genomics Consortium’s SCZ2
schizophrenia GWAS data (https://www.med.unc.
edu/pgc/downloads) and access GenBank human EST data.
Additionally, the Broad Institute’s Ricopili tool was used to
visualise schizophrenia GWAS SNPs from the ‘PGC_
SCZ52_may13’ dataset across the MIR137 locus
(http://www.broadinstitute.org/mpg/ricopili/).
LD analysis used SNP genotype data from the CEU/CEPH
cohort, spanning the region chr1:98,498,912–98,595,043
(GRCh37/hg19) and downloaded from the HapMap
Genome Browser,
(http://hapmap.ncbi.nlm.nih.gov/), release #28. LD
analysis was performed using Haploview 4.2,
(www.broad.mit.edu/mpg/haploview/) with the following
parameters: Hardy-Weinberg p-value cut-off, 0.001; mini-
mum genotype cut-off, 75 %; maximum number of Mendel
errors, 1; minimum minor allele frequency, 0.01) and pair-
wise tagging analysis performed (r2 threshold, 0.8).
Haplotype blocks were determined using 95 % confidence
intervals (Gabriel et al. 2002). HaploReg V4.1 (http://www.
broadinstitute.org/mammals/haploreg/haploreg.php) (Ward
and Kellis 2012) was used to access chromatin state and his-
tone data from the Roadmap Epigenomics Consortium
(Roadmap Epigenomics et al. 2015) in order to assess poten-
tial activity of ECRs in vivo.
Generation of pGL3P Reporter Gene Constructs
All evolutionary conserved regions in this study were
amplified by PCR from pooled mixed-gender human
genomic DNA preparations (Promega) using Phusion
High-Fidel i ty DNA Polymerase (New England
Biolabs). Amplified fragments were cloned into the
pGL3P luciferase reporter vector (Promega) using
Gibson Assembly Cloning Kit (New England Biolabs)
as described in manufacturer’s protocol, and transformed
into XL10-Gold ul t racompetent ce l l s (Agi lent
Technologies). In order to allow directional cloning,
primers used for amplification included tails of 16–
20 bp, complementary to the sequence flanking the cut
site of the vector into which the fragments were to be
cloned.
The following primer sets were used (5′➔ 3′). Underlined
sequence indicates 16–20-bp flanking region complementary
to cloning vector:
MIR 1 Fwd: GCAGTGGCTGTAAGATGAGGA
MIR 1 Rev: AGAGGCCTGGAGTCTGTGAC
MIR 2 Fwd: CCCCATGATGTTCTCATACCA
MIR 2 Rev.: TACAGCCACTGCAAATACGG
MIR 3 Fwd: AGCTCTTACGCGTGCTAGCTGC
ACTTTGCATTCCTC.
MIR 3 Rev : AGATCGCAGATCTCGAGCTCA
CACTTCCTAACTGGT
MIR 4 Fwd: AGCTCTTACGCGTGCTAGTGCC
CTTGTCTAATGAA
MIR 4 Rev : AGATCGCAGATCTCGAGCATT
CAGGACTCTAGTCT
MIR 5 Fwd: AGCTCTTACGCGTGCTAGAGAA
GAGGATTTGTGGGCTAC
MIR 5 Rev: AGATCGCAGATCTCGAGGGCT
TGGGATACCTGACAATTAGCAAC
MIR 6 Fwd: AGCTCTTACGCGTGCTAGAGCC
TCTACAATTCAGGA




Fig. 1 Schizophrenia genome-wide associated SNPs and evolutionary
conserved regions (ECRs) at the MIR137 locus. Visualisation of the
Psychiatric Genomics Consortium’s May 2013 schizophrenia GWAS da-
ta across the full schizophrenia-associated locus (chr1:98298371-
98595000, GRCh37/hg19), using the Broad Institute’s Ricopili tool.
The boxed region including MIR137 and upstream regions
(chr1:98448000-98595000; GRCh37/hg19) displays the highest signal
at this locus in terms of association for schizophrenia, suggesting that
MIR137 and potential upstream regulatory regions are likely to be the
causal association at this locus. The boxed region is expanded below, and
schizophrenia GWAS SNP data overlaid onto species conservation data
from the ECR browser. Statistically significant schizophrenia GWAS
SNPs are represented by coloured circles or diamonds above the green
line (p = 5.0e-08). Red numbers 1 and 2 highlight the schizophrenia
GWAS SNPs rs1625579 and rs1198588, respectively. ECRs selected
for study are boxed and numbered. Conserved peaks between boxes 2
and 3 represent the microRNA and its proximal promoter, which were not
included in this analysis, but highlight conservation as an indicator of
functionality
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MIR 7Rev : AGATCGCAGATCTCGAGTGCT
TCAGTGTAACTACTG
Genomic co-ordinates (GRCh37/hg19) for the ECR frag-
ments amplified are as follows:
MIR 1: chr1:98499831-98500934 (1104 bp)
MIR 2: chr1:98500923-98502814 (1892 bp)
MIR 3: chr1:98525381-98525895 (515 bp)
MIR 4: chr1:98538705-98540267 (1563 bp)
MIR 5: chr1:98552809-98554083 (1275 bp)
MIR 6:chr1:98567339-98567854 (516 bp)
MIR 7: chr1:98592252-98592661 (410 bp)
Cloning of inserts was verified by bi-directional sequenc-
ing using standardised primers.
Culture of SH-SY5Y Human Neuroblastoma Cells
Human neuroblastoma cell line, SH-SY5Y (ATCC CRL-
2266), was grown and maintained in a 50:50 mix of
Minimal Essential Medium Eagle (Sigma) and Nutrient
Mixture F-12 Ham (Sigma), supplemented with 10 % foetal
bovine serum (ThermoScientific), 1% penicillin/streptomycin
(100 U/ml, 100 mg/ml; Sigma), 1 % (v/v) 200 mM L-gluta-
mine (Sigma), and 1 % (v/v) 100 mM sodium pyruvate
(Sigma). Cells were incubated at 37 °C with 5 % CO2.
Transfection and Dual Luciferase Assays
SH-SY5Y cells were seeded at approximately 100,000 cells
per well in 24-well plates. After overnight incubation, cells
were co-transfected with 2 μg reporter DNA and 20 ng
pMLuc-2 (a TK renilla luciferase vector used as an internal
control for normalisation; Novagen, USA) using TurboFect
Transfection Reagent (ThermoScientific/Fermentas), accord-
ing to manufacturer’s protocol.
Luciferase reporter assays were performed 48 h post-trans-
fection. Luciferase activity of reporter constructs was mea-
sured using a Dual Luciferase Reporter Assay System
(Promega) using 20 μl lysate from transfected cells according
to manufacturer’s instructions. Assays were carried out on a
Glomax 96-well microplate Luminometer (Promega). Two-
tailed t test for significance compared fold change in luciferase
expression to the vector containing the minimal promoter
alone (*P < 0.1, **P < 0.01, ***P < 0.001) N = 4.
Results
Identification of ECRs at the MIR137 Locus
Genome-wide significant variants associated with complex
disorders are overwhelmingly in non-coding regions of the
genome and potentially exert their effect through regulation
of the transcriptome, rather than via primary changes in
coding sequence. Identifying non-coding evolutionary con-
served regions (ECRs) is one method of determining regula-
tory domains that may influence gene expression at the
MIR137 locus. We used the ECR Genome Browser to screen
for ECRs across this region based on a seven-way alignment
of vertebrate genomes. This identified four highly conserved
regions upstream of MIR137 (MIR 3, 4, 6 and 7). Three ad-
ditional ECRswere selected for study due to their proximity to
highly significant schizophrenia GWAS SNPs, namely
rs1625579 and rs1198588; two were intronic, MIR 1 and 2,
and one was upstream of MIR137, MIR 5. ECRs are herein
named MIR 1–7 (Fig. 1).
Regions EncompassingMIRECRs 1, 2, 3, 5 and 7 Contain
Schizophrenia GWAS SNPs
Following identification of the above ECRs, bioinformatic
analysis was carried out using the UCSC Genome Browser
to align the Psychiatric Genomics Consortium’s latest schizo-
phrenia GWAS data (PGC2, accessible at: http://www.med.
unc.edu/pgc/downloads) over the MIR137 locus ECRs.
PGC2 data showed that the strongest GWAS signal at this
locus was across MIR137 itself and extended significantly
into the upstream region (Fig. 1). Current data shows 80
schizophrenia GWAS SNPs across the 96.1-kb region con-
taining the seven selected ECRs (chr1:98,498,912–
98,595,043; GRCh37/hg19), with three of these GWAS
SNPs being within MIR 3, one in MIR 7, and an additional
seven GWAS SNPs adjacent to MIR ECRs 1, 2 and 5 (Fig. 2).
Linkage disequilibrium analysis was carried out using the
nine ECR schizophrenia GWAS SNPs for which data was
available in the HapMap CEU cohort, with additional non-
GWAS HapMap SNPs from these regions included (Fig. 2).
Haplotype blocks were identified in HaploView using the de-
fault parameters as specified by Gabriel et al. (Gabriel et al.
2002). Of the GWAS SNPs used in this analysis, seven were
found to be in a haplotype block, linking MIR ECRs 1, 2, 3
and 5 over a region of ~54.9 kb (chr1:98,499,795–
98,554,659). This analysis also showed that schizophrenia
GWAS SNPs within the ECRs at the MIR137 locus are pref-
erentially in linkage disequilibrium with each other, whereas
non-GWAS SNPs in the same ECRs are not. This indicates
that the schizophrenia-associated SNPs may function in com-
bination and mediate risk through a shared or combined
mechanism.
Bioinformatic Analysis of ECR Function In Vivo
HaploReg V4.1 was used to access chromatin structure and
histone modification data from the Roadmap Epigenomics
Consortium. This data showed that the ECRs MIR 1 and 2
are predicted to be enhancers in the brain, displaying
H3K4me1, H3K4me4 and H3K27ac histone modifications
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Fig. 2 Linkage disequilibrium (LD) analysis of SNPs across theMIR137
ECRs: a) Schematic of MIR137 and upstream region containing the
ECRs of interest, with PGC2 schizophrenia GWAS data overlaid, show-
ing 80 schizophrenia GWAS SNPs across this locus. ECRs are numbered
1–7 and visualised as peaks on the 100 vertebrates base wise conservation
track from the UCSC Genome Browser. b) LD analysis of SNPs at the
MIR ECRs was carried out using SNP genotype data from the HapMap
CEU cohort, with D’ values shown. Data for 9 of the schizophrenia
GWAS SNPs (starred*) was available in this cohort, and analysed along-
side data for non-GWAS HapMap SNPs within the same ECRs. In this
analysis, a haplotype block was found to link SNPs from ECRsMIR 1–5,
with schizophrenia GWAS SNPs at MIR 1, 2, 3 and 5 in strong linkage
disequilibrium with each other
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across multiple brain regions, which are indicative of active
regulation and transcription at these loci. Methylation data for
MIR 6 also shows H3K4me1 marks at a number of brain
regions including the hippocampus, cingulate gyrus, germinal
matrix and across the foetal brain, consistent with this ECR
being an active or poised transcriptional regulator in these
tissues (Fig. 3a, b, f).
Conversely, analysis of data across MIR 3, 4 and 5 predict-
ed these regions to be active regulators during development,
with histone modifications and chromatin state data consistent
with transcriptional regulatory activity in multiple embryonic
and induced pluripotent stem cell lines, as well as in stem cell-
derived neuronal progenitor or cultured neuron cells. In addi-
tion to H3K4me1 histone modifications, H3K27ac and
H3K9ac marks are also seen across MIR 5 in multiple embry-
onic and induced pluripotent stem cell lines, suggesting active
transcription from a nearby promoter during development
(Fig. 3c, d, e). No relevant data was seen over the MIR 7
ECR locus.
Transcriptional Regulatory Activity of MIR ECRs
The seven selected ECRs were cloned into pGL3P luciferase
reporter vector, and potential transcriptional regulatory func-
tion was verified by dual luciferase reporter assay in the SH-
SY5Y neuroblastoma cell line (Fig. 4a). When compared to
the baseline expression of luciferase from the unmodified
pGL3P vector containing a minimal promoter alone, five of
the seven selected ECRs were shown to act as positive regu-
lators of reporter gene expression (MIR 1, 3, 4, 6, 7). The two
remaining ECRs (MIR 2 and 5) decreased expression of the
reporter gene. MIR 1 and MIR 6 were found to be the most
active ECRs in our reporter gene assay in the neuroblastoma
cell line, SH-SY5Y.
As theMIR137 locus is shown to be highly associated with
schizophrenia through GWAS, new ESTs and RNAs from
within this region warrant further study for their potential in-
volvement in brain development and function. In this regard,
further bioinformatic investigation of the MIR 1 region using
GenBank data on human ESTs showed an uncharacterised
transcript (AW901379) adjacent to this ECR, identified in
nervous tissue (Fig. 4b). Histone modification data across this
locus from the Roadmap Epigenomics Consortium showed
that MIR 1 displayed H3K4me1 modifications in human em-
bryonic stem cells and derived neuronal progenitor cells, con-
sistent with this site being a poised or active transcriptional
regulator in these cells. The same region also displayed
H3K4me1 modifications in the foetal brain, as well as seven
of the eight brain regions tested, with H3K4me3 marks (in-
dicative of actively transcribed promoter regions) seen in the
hippocampus, cingulate gyrus, inferior temporal lobe, angular
gyrus, dorsolateral prefrontal cortex and foetal brain (Fig. 3a).
This evidence suggests that the MIR 1 ECR may act as a
promoter or modulator of expression for an uncharacterised
RNA at this locus in CNS tissues.
Discussion
Analysis of GWAS data has demonstrated that many non-
coding regions of the genome are implicated in genetic sus-
ceptibility to psychiatric illness (Ripke et al. 2013). This might
suggest that many of these associations are highlighting reg-
ulatory mechanisms that modulate tissue-specific or stimulus-
inducible regulation of gene expression or RNA processing
(Quinn et al. 2013). This would be consistent with the episodic
nature of many psychiatric conditions, in which regulatory
mechanisms would be affected by an environmental chal-
lenge, thereby highlighting a major role for gene-
environment interactions in such disorders.
In our study, we identified seven non-coding ECRs with
potential transcriptional regulatory function at the
schizophrenia-associated MIR137 locus (Fig. 1). GWAS
SNPs within MIR 3 and 7, and adjacent to MIR 1, 2 and 5,
would support a functional role for these elements in the reg-
ulation of expression from this locus with relevance to schizo-
phrenia (Fig. 2). Data from the Epigenomics Roadmap
Consortium on the chromatin and histone modifications
across the ECRs showed that MIR 1, 2 and 6 are predicted
to function as active regulatory elements in multiple brain
tissues. This supports a role for these ECRs in regulating ex-
pression from this locus in the human brain. Further data also
suggested and that MIR 3, 4 and 5 are functionally active in
both embryonic and induced stem cell lines, as well as stem
cell derived neurons (Fig. 3). The data banks we have
accessed may therefore point to different times in develop-
ment and in the adult when our potential regulators would
be active. This data may be useful in delineating mechanisms
in the development of schizophrenia, e.g. that MIR 3, 4 and 5
may be important in the foetus and therefore focus our model
for their function on the developmental aspects of
schizophrenia.
We have demonstrated through reporter gene assays that
the seven ECRs selected at the MIR137 locus can modulate
Fig. 3 Chromatin state and histone modifications at MIR ECRs in the
brain and embryonic tissues. Data from the Roadmap Epigenomics
Consortium shows that MIR 1, 2 and 6 (3a, b and f) are active
regulators of transcription in many areas of the human brain, whereas
MIR 3, 4, and 5 (3c, d and e) are active in embryonic and induced
pluripotent stem cells, and may function to regulate transcription at this
locus during development. Chromatin states: Enh = enhancer, EnhA1/2
= active enhancer 1 or 2, EnhAc = enhancer acetylation only, EnhAF =
active enhancer flank, EnhW1/2 = weak enhancer 1 or 2, PromP = poised
promoter, PromU = promoter upstream transcriptional start site, TssA
= active transcription start site, TssAFlank = flanking active
transcriptional start site. Histone modifications: Enh = enhancer, Pro =
promoter. Black = no available data
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reporter gene expression in the neuroblastoma cell line, SH-
SY5Y (Fig. 4). All but one of the ECRs (MIR 5) is conserved
at least to the chicken genome, and we and others have dem-
onstrated that similar evolutionary conservation has identified
domains that can support tissue specific marker gene expres-
sion in mouse transgenic models (Davidson et al. 2011;
Davidson et al. 2006) and in the chicken (Khursheed et al.
2015). In addition, expression data from GenBank suggests
an uncharacterised, nervous tissue-expressed transcript origi-
nating from the MIR 1 locus, with histone modification data
indicating active transcription around this ECR in multiple
regions of the human brain (Fig. 3a and 4b).
Conclusion
In conclusion, bioinformatic analysis identified seven highly
conserved, functional ECRs at the MIR137 locus. The tran-
scriptional regulatory activity of the ECRs, predicted from
available ENCODE and expression data, was validated by
reporter gene assay, and in conjunction with supporting data
from the PGC schizophrenia GWAS studies, suggests a func-
tional role for these sequences in the regulation of expression
at the MIR137 locus. This demonstrates multiple ‘gene x en-
vironment’ pathways that could impact on MIR137
expression levels either individually or synergistically to mod-
ulate CNS behaviour, contributing to schizophrenia and po-
tentially other brain-related conditions.
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